Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer

BACKGROUND: Peripheral blood biomarkers to immunotherapy have attracted more and more attentions owing to noninvasive nature. This study was designed to identify a panel of tumor associated autoantibodies (TAAbs) in plasma to predict the clinical outcome of ICIs-based treatment in advanced NSCLC pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Juan, Zhao, Jing, Jia, Qingzhu, Chu, Qian, Zhou, Fei, Chu, Xiangling, Zhao, Wencheng, Ren, Shengxiang, Zhou, Caicun, Su, Chunxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010683/
https://www.ncbi.nlm.nih.gov/pubmed/33816260
http://dx.doi.org/10.3389/fonc.2021.625578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010683/
https://www.ncbi.nlm.nih.gov/pubmed/33816260
http://dx.doi.org/10.3389/fonc.2021.625578

Ejemplares similares